What's breaking now, across thousands of outlets.
Ziltivekimab's failure in a key trial spurred share sell-offs for Novo and other biotechs, as it suggested trouble for different cardiovascular drugs that also target inflammation.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Headquartered in New York City, Meritus is a network of distributors of industrial, medical, and specialty gases and welding and safety supplies.
A new poll offers an early snapshot of Americans’ attitudes toward robots in various corners of everyday life.
Article URL: https://www.lighthousereports.com/investigation/big-food-vs-the-people/ Comments URL: https://news.ycombinator.com/item?id=49124858 Points: 264 # Comments: 172
Katalyst Space's LINK spacecraft is recovering from an unexpected spin in orbit, and will need a little more time to rescue NASA's falling Swift observatory.
[Independent (Kampala)] Kampala -- Experts have urged those who already received their first injection of the twice-yearly HIV preventing drug Lenacapavir to consider using combination prevention…
BUNIA, Democratic Republic of Congo – Victorine Ngwobu Kasemi is the director of nursing at the Evangelical Medical Centre in Bunia, the epicentre of the Democratic Republic of Congo’s record-breaking…
